Licofelone - Novel Analgesic and Anti-Inflammatory Agent for Osteoarthritis

 

Key Data:

Drug (Brand / Generic)
Licofelone (ML3000)
Company / Licensee
Merckle GmbH and EuroAlliance partners Alfa Wassermann and Lacer
Therapy Class
Dual COX/LOX inhibitor
Product Description
Inhibits the action of COX and 5-LOX enzymes
Current Indication
Treatment of pain and inflammation associated with OA
Market Sector
CNS - pain
Development Status
Phase III



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development